Search - tctmd.com

Displaying 521 - 540 of 2597

Sort: Relevancy | Date

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

Presentation TCT 2022

TCT 386: A Comparative Meta-Analysis of Newer Percutaneous Left Atrial Appendage Occlusion Devices

Presenter: Gauravpal Singh Gill

September 18, 2022

Presentation TCT 2022

Current FDA-Approved Devices: How to Select; Lesion-Specific Differences

Presenter: Reda Ibrahim

September 18, 2022

News Conference News TCT 2022

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

L.A. McKeown

September 18, 2022

Presentation TCT 2022

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

Presenter: Walid Saliba

September 18, 2022

Presentation TCT 2022

Imaging Controversies in LAAC: Preprocedural CT, Role of ICE, and Postprocedural Imaging

Presenter: Shephal Doshi

September 18, 2022

Presentation TCT 2022

Ongoing Clinical Trials and the Future of LAAC

Presenter: Matthew Price

September 18, 2022

Presentation TCT 2022

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

Presenter: Brennan Vogl

September 18, 2022

Presentation TCT 2022

Recent Clinical Trials & Registries: Update 2022

Presenter: Kolja Sievert

September 18, 2022

Presentation TCT 2022

OpSens SavvyWire: Device Review & Case Example

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

Excluding the Infarcted LV Apical Segment of the Heart: The Bioventrix Device and Pivotal Study

Presenter: Rishi Puri

September 18, 2022

Presentation TCT 2022

Reshaping the Failing Heart From Inside the LV Chamber: The Accucinch Device and Pivotal Study

Presenter: Kendra Grubb

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Presentation TCT 2022

Future Vision: Clinical and Technology Requirements for the Successful Development of Transcatheter Tricuspid Therapy Programs

Presenter: Azeem Latib

September 17, 2022

Presentation TCT 2022

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

Presenter: David Cohen

September 17, 2022

Presentation TCT 2022

What Device for What Patient: Insights From the CLASP IID Registry

Presenter: Jörg Hausleiter

September 17, 2022

Presentation TCT 2022

Physiologic and Hemodynamic Parameters Influencing Device Selection and Clinical Outcomes

Presenter: Neil Fam

September 17, 2022

Presentation TCT 2022

To Repair or Replace: A Treatment Algorithm Derived from Multimodality Imaging

Presenter: Rebecca Hahn

September 17, 2022

Presentation TCT 2022

Transcatheter Tricuspid Valve Intervention: Anatomical and Technological Challenges

Presenter: Thomas Modine

September 17, 2022

Presentation TCT 2022

Definining the Appropriate Patients for TTVI: What Have We Learned From Surgery

Presenter: Robert Smith

September 17, 2022

Advertisement

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

TCT 386: A Comparative Meta-Analysis of Newer Percutaneous Left Atrial Appendage Occlusion Devices

Current FDA-Approved Devices: How to Select; Lesion-Specific Differences

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

Imaging Controversies in LAAC: Preprocedural CT, Role of ICE, and Postprocedural Imaging

Ongoing Clinical Trials and the Future of LAAC

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

Recent Clinical Trials & Registries: Update 2022

OpSens SavvyWire: Device Review & Case Example

Excluding the Infarcted LV Apical Segment of the Heart: The Bioventrix Device and Pivotal Study

Reshaping the Failing Heart From Inside the LV Chamber: The Accucinch Device and Pivotal Study

FLASH: More Data to Support Mechanical Thrombectomy in PE

Future Vision: Clinical and Technology Requirements for the Successful Development of Transcatheter Tricuspid Therapy Programs

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

What Device for What Patient: Insights From the CLASP IID Registry

Physiologic and Hemodynamic Parameters Influencing Device Selection and Clinical Outcomes

To Repair or Replace: A Treatment Algorithm Derived from Multimodality Imaging

Transcatheter Tricuspid Valve Intervention: Anatomical and Technological Challenges

Definining the Appropriate Patients for TTVI: What Have We Learned From Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content